Abstract Dysregulation of intestinal epithelial cell performance is associated with an array of pathologies whose onset mechanisms are incompletely understood. While whole-genomics approaches have been valuable for studying the molecular basis of several intestinal diseases, a thorough analysis of gene expression along the healthy gastrointestinal tract is still lacking. The aim of this study was to map gene expression in gastrointestinal regions of healthy human adults and to implement a procedure for microarray data analysis that would allow its use as a reference when screening for pathological deviations. We analyzed the gene expression signature of antrum, duodenum, jejunum, ileum, and transverse colon biopsies using a biostatistical method based on a multivariate and univariate approach to identify region-selective genes. One hundred sixty-six genes were found responsible for distinguishing the five regions considered. Nineteen had never been described in the GI tract, including a semaphorin probably implicated in pathogen invasion and six novel genes. Moreover, by crossing these genes with those retrieved from an existing data set of gene expression in the intestine of ulcerative colitis and Crohn's disease patients, we identified genes that might be biomarkers of Crohn's and/ or ulcerative colitis in ileum and/or colon. These include CLCA4 and SLC26A2, both implicated in ion transport. This study furnishes the first map of gene expression along the healthy human gastrointestinal tract. Furthermore, the approach implemented here, and validated by retrieving known gene profiles, allowed the identification of promising new leads in both healthy and disease states.
Introduction
The gastrointestinal (GI) tract is a complex system characterized by multiple biological functions that are anatomically distributed. Besides being the site for food processing and nutrient absorption, it is also the largest immune organ of the body and, being at the interface with the external environment, constitutes an important barrier against ingested pathogens and toxins. Furthermore, the intestine is the home of a large microbial community, roughly comprising 10 14 cells, which is now considered an additional metabolic organ of our body (Backhed et al. 2005) . These multiple functions significantly rely on the epithelial cells. Given their ability to integrate a large variety of environmental signals, including those coming from the gut resident microbiota, these cells are the main regulators of intestinal mucosal homeostasis (Clavel and Haller 2007; McCole and Barrett 2007) . Hence, dysregulation of intestinal epithelial cell performance is associated with an array of different pathologies. For example, several studies have shown that immune and epithelial cells concur with T-helper cells in the pathophysiology of inflammatory bowel disease (IBD) by undergoing phenotypic modifications that mainly affect the maintenance of the epithelial barrier. These modifications include reduced production of a-defensins (Wehkamp et al. 2005 ), altered expression of mucin genes (Buisine et al. 1999 (Buisine et al. , 2001 ), expression of IL-15 and TGFb (Yoshikai 1999) , and dysregulation of the pregnane X receptor target genes (Langmann et al. 2004) . Also, it has been suggested that differences exist in the phenotypic features of epithelial cells between ulcerative colitis (UC) and Crohn's disease (Andoh et al. 2001) , although the onset mechanisms of these pathologies are incompletely understood.
Global gene expression profile analyses of diseased tissues greatly contributed to the understanding of how deviation from healthy biological pathways may be associated with specific phenotypes. These include neoplastic diseases such as colorectal cancer (Reichling et al. 2005; Sugiyama et al. 2005) , celiac disease (Diosdado et al. 2004; Juuti-Uusitalo et al. 2007) , and idiopathic diseases such as IBD (Csillag et al. 2007; Langmann et al. 2004; Moehle et al. 2006) . The interpretation of a pathology-related gene expression signature relies on knowing the healthy profile. Nonetheless, genomics approaches have seldom been used for the study of the unaffected GI tract (Fleet 2007) . Initial studies conducted in rodents furnished a basic understanding of gene expression modulation along the healthy GI tract. In a pioneer work, a gene expression analysis based on a cDNA array representing about 8600 genes showed that biological functions and gene expression are highly correlated along the murine GI tract (Bates et al. 2002) . Indeed, while some transcripts are commonly found in different regions, distinct intestinal segments are characterized by specific gene expression profiles (Anderle et al. 2005; Fleet 2007; Mutch et al. 2004 ). Other studies examined gene expression along the crypt-villus axis in the small intestine and showed that a specific gene expression program characteristic of intestinal epithelial cell maturation also exists (Mariadason et al. 2005; Stegmann et al. 2006) . On the other hand, less is known about how gene expression is modulated in the healthy human GI tract. In the large intestine, the existence of transcripts that are specific to its different regions as well as of transcripts that are gradually modulated longitudinally has been shown (Glebov et al. 2003; Lapointe et al. 2008 ). The regional character of gene expression in the large intestine could be partially traced back to the different embryological origins of its proximal and distal parts (Lapointe et al. 2008) , but it has also been suggested to play a role in the susceptibility of the distinct colonic segments to different types of colorectal carcinomas (Glebov et al. 2003) .
To our knowledge, gene expression variation along the cephalocaudal axis of the whole human gastrointestinal tract has not been investigated. By analyzing gene expression in biopsies taken from the stomach, duodenum, jejunum, ileum, and transverse colon of healthy adults, this study contributes to our understanding of gene expression evolution along this system. Furthermore, this work addresses how the generated profiles of gene expression can be used as a reference when screening for pathological deviations. The underlying assumption of current microarray studies is the belief that it is, in principle, possible to fully describe a biological sample, a snapshot of a precise physiological state, by a set of measures of gene expression levels. In this context, the levels of mRNA that, for example, Affymetrix probe sets account for can be interpreted as the descriptors of a given physiological state or biological sample. This information is sometimes difficult to exploit for the identification of specific targets or disease biomarkers because of the large amount of noise intrinsic to microarray analyses. Noise in this context can be related to fluctuation due to the experimental conditions, to the presence of outliers, and to genes presenting no modulation between groups.
In this study we produced a map of gene expression in different regions of the healthy human GI tract and implemented a biostatistical method for noise filtering and statistical significance assessment. This method is based on the combination of a multivariate approach, principal component analysis (PCA) for a first data compression and signal extraction, and an univariate approach using robust statistics for the estimation of statistical significance of the selected genes. The built workflow furnishes a flexible but robust way to extract knowledge to recognize significant expression patterns with high confidence within the set of the identified modulated genes.
By first identifying specific biomarkers of healthy human gut segments and then by crossing them with genes mostly affected in IBD we were able to identify both interesting new leads such as novel ileal and colonic genes, and promising candidate biomarkers of Crohn's disease and/or ulcerative colitis in ileum and/or colon.
Materials and methods

Samples collection
Biopsies (10-15 mg) were collected by upper GI endoscopy (with a pediatric colonoscope to reach the proximal jejunum) and colonoscopy from the antrum, duodenum, jejunum, ileum, and transverse colon (hereafter colon) of two male and two female healthy human subjects recruited in accordance with the Helsinki declaration and with previous approval by the Ethical Committee of the Canton de Vaud, Lausanne, Switzerland. The individuals, informed about the scope of the study, were between 20 and 30 years, did not have any gastrointestinal or cardiovascular disorder, did not use any drugs during the 4 weeks before sampling, and were Helicobacter pylori negative. Study participants were required to fast for 12 h and were given a bowel preparation (Fordtran's and Cololyt solutions) to prepare the intestine the evening before endoscopy. All endoscopic procedures were performed by a gastroenterologist at the University Hospital of the Canton de Vaud (CHUV), Lausanne, Switzerland. The biopsies, which were expected to mainly contain mucosal tissue, were snap-frozen and stored at -80°C until use (within 2 weeks from sampling).
RNA isolation and gene array hybridization
Total RNA was extracted using the TriPure Isolation reagent (Roche Diagnostics AG, Rotkreuz, Switzerland) and Dnase-I treated and purified with the Nucleospin kit (MachereyNagel AG, Oensingen, Switzerland). RNA quality was assessed with the Agilent 2100 Bioanalyzer and the RNA 6000 Nano Chip kit (Agilent Technologies, Waldbronn, Germany). RNA (5 lg) from each sample was then independently amplified, labeled, and hybridized to the HG-U133A Affymetrix chip (Affymetrix, High Wycombe, UK), according to the manufacturer's instructions. The chips were scanned at 488 nm with an argon-ion laser (Agilent Biotechnologies and Affymetrix) and expression signals were generated and normalized using the MAS 5.0 algorithm (Affymetrix). All chips used in this study were processed in line with and passed the quality control steps built in the Affymetrix standard procedure for gene array hybridization, including spiking with a prokaryotic control cocktail to assess hybridization performance. The entire data set has been deposited at the NCBI Gene Expression Omnibus (GEO) repository (http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE10867. Gene expression of the samples was not investigated with any additional technique since microarray measurements have been shown to be reproducible across different platforms and therefore they can be used independently (Chou et al. 2008; Shi et al. 2006 ).
Identification of region-selective biomarkers
After a preprocessing step, including normalization (MAS 5.0, Affymetrix) and log transformation of the hybridization signals, the data were organized into a matrix of 20 rows and 22,283 columns, corresponding to the number of arrays (each representing a biological sample of one of the five gut compartments labeled according to the gender of the corresponding individual) and the number of probe sets (variables), respectively. To check for intrinsic clustering among the 20 biological samples, unsupervised PCA and hierarchical clustering (HCA; Ward's method, Euclidean metric) analysis were performed. Region-specific gene biomarkers were identified based on the loadings that describe the relative contributions of the probe sets' effect on the decomposition of the data. In a second stage, loadings (for probe sets) and scorings (for samples) were mapped onto a biplot to determine regionspecific gene regulation. The selected genes were then crossed with the highly variable ones identified in the GSE1152 data set, publicly available at the GEO repository. All analyses were performed using R Software and Bioconductor packages (Gentleman et al. 2004) . The statistical significance of differential gene expression was determined using a modified ANOVA according to the Global Error Assessment procedure (Mansourian et al. 2004) . Finally, to bypass the problem of multiple Present (P) and Absent (A) calls for the same gene/condition, we computed a virtual chip using the robust average of the probe sets' values of the same gene in the different chips and then computed the P/A calls using the Affymetrix MAS 5.0 algorithm.
Bioinformatics analyses
Probe sets were annotated using ENSEMBL v28 and NetAffx (Affymetrix) (grade 1), preferring the former if discordant (grade 2) or the latter if the former was missing (grade 3). Probe sets representing unknown sequences were tentatively annotated (grade 4) by protein domain recognition analysis using HMMer against Pfam (http://pfam. sanger.ac.uk/) and with PSI-Blast (Altschul et al. 1997) . The level of confidence of the annotation was expressed as an E value, i.e., the probability of detecting the similarity by chance, as calculated by PSI-Blast (cutoff = 10E-5). Gene expression profiles were represented using Spotfire Decision Site for Functional Genomics 7.3 (TIBCO Spotfire Inc., Palo Alto, CA). An automated literature search based on WordStat v4.0.19 and SimStat v2.5.1 software (Provalis Research, Montreal, CA), followed by manual refinement, was used to identify genes that had never been described in the GI tract.
Results and discussion
Global analysis of the gastrointestinal tract transcriptome
Total mRNAs prepared from the biopsies of antrum, duodenum, jejunum, ileum, and colon of two males and two females were independently hybridized to the Affymetrix gene chip U133A, which contains 22,283 probe sets representing 14,593 UniGene clusters for a total of 20 microarrays used. Villin (205506_at), occludin (209925_at), and the transcription factor Elf3 (201510_at), three genes expressed exclusively in the epithelium, were scored present and highly expressed in all regions. On the other hand, CD80 (207176_s_at), CD86 (205685_at), and CD14 (201743_at), expressed in immune cells, and epimorphin (207346_at), expressed in mesenchymal cells, were scored absent and/or with very low hybridization intensities. Therefore, we can assume that the expression profiles produced in this study represent mainly epithelial cells. A blind unsupervised approach was used to assess the samples' separability while reducing the amount of noise by complementing PCA and HCA analyses. The representation of the data on the two first principal components clearly showed two possible outliers, one from antrum gathering with ileum samples and one from ileum gathering with jejunum samples (data not shown). These two samples were removed from further analysis since deviation of a single representative point from the cluster of its peers, at a distance as great as ten times the standard deviation of the related cluster, seemed suspicious, and the chance of this representing a real biological effect was estimated to be vanishing. HCA and PCA performed on the remaining 18 samples gave consistent and overlapping results and provided the basis to further restrain the analysis to those probe sets, out of the original 22,283, that varied most significantly among them. A magnitude of every probe set contribution was estimated and the original data set was reduced to 199 significant probe sets (Supplementary Table 1 ). These probe sets, selected on the basis of their important loadings (high loading corresponds to high variance), are those mainly contributing to the observed intracluster energy and therefore are responsible for sample separation. When carrying out HCA and PCA on these probe sets, we found that samples were not separable according to gender but were rather clearly stratified according to the gastrointestinal region (Fig. 1a, b) . PCA was able to capture more than 85% of the information contained in the raw data set. Sample separation was particularly evident for antrum, colon, and ileum, while duodenum and jejunum were somewhat more similar. This was further highlighted by analyzing the region-specific modulation of the 199 selected probe sets through scorings and loadings mapping on a biplot (Fig. 1c) . Thirty-eight probe sets were modulated in antrum, 20 in ileum, and 33 in colon. The identification of probe sets selective of duodenum and jejunum turned out to be more difficult. Of a total of 108 probe sets specifically modulated in these two compartments, we could identify 21 probe sets in duodenum and 15 in jejunum, while the remaining 72 were jointly modulated in both tissues. No probe set expressed in all regions but one was found. All of the 199 probe sets were found to be statistically significantly differentially expressed by using the Global Error Assessment (GEA) model (P \ 0.001), except for 220038_at which was therefore excluded from further examination.
Identification and expression analysis of healthy intestinal regions' selective genes
The 198 probe sets selected above were assigned to 166 unique genes (Fig. 2) that we defined as region-selective but not necessarily region-specific, with some expressed in more than one GI segment according to Affymetrix present calls (Supplementary Table 1) . Region-selective genes are preferentially, but not exclusively, expressed in a given region and are likely to be involved in its major physiological functions. Region-specific genes are restricted to that region and may be used to distinguish it (Hsiao et al. 2001 ). Automated literature mining followed by manual refinement was used for the 166 genes to discriminate between novel and existing information. One hundred sixteen genes were found to be associated with known intestinal functions and their expression profile corresponded to previously reported data. In particular, the expression profile of most of these genes reflected intestinal biological functions that are anatomically distributed, including digestion in the upper regions and absorption and excretion in the middle and lower parts of the GI tract. This validated our gene-selection approach and these genes were not further investigated. Thirty-one genes had already been described in the GI tract but their proximal-to-distal profile had not been documented. These are NMU, MUC1, MUC6, FOXA2, GATA4, ORM1, and CRIP2 selective of antrum; TM4SF4 and SERPINB5 selective of duodenum; GPR172B, SFRP5, HTR1D, BST1, and RASA4 selective of duodenum and jejunum; CLDN15 selective of jejunum; UGT2B17, CFTR, MUC2, ZG16, and PPP1R12A selective of ileum; and PDE9A, HOXA9, HOXA6, PYGB, POSTN, CEACAM5, CD24, TSPAN-1, CNNM4, HK2, and RAR-RES1 selective of colon. Finally, 19 genes had never been reported in the human GI tract. These include SEMA6A, a semaphorin involved in the control of actin filament dynamics (Klostermann et al. 2000) and possibly in pathogen invasion (Laurent et al. 1999 ) and found to be ileumselective; PCDH21, a cadherin suggested to be involved in the formation of neuronal networks in the olfactory bulb (Nakajima et al. 2001 ) and found to be colon-specific; MS4A12, a member of the membrane-spanning 4A family thought to be involved in signal transduction (Liang and Tedder 2001) which is colon-specific; CLIC3, a nuclear chloride channel found to be specific of antrum; and CLCA4, a Ca 2? -activated chloride channel which is colon selective. Six of the 19 genes were unknown genes that were tentatively annotated as explained in Materials and methods. Among these we identified, based on protein sequence analysis, FLJ22880 as a new putative member (E = 3.8e -134 ) of the L6 family of transmembrane proteins (Maecker et al. 1997; Wright et al. 2000) that is selective of small intestine and likely to be implicated in signal transduction events, and a dihydroxyacetone kinase (DAK-1, E = 7.5e -128 ; DAK-2, E = 4.3e -69 ) that catalyzes the first limiting step of glycerol utilization (glycerone to glycerone phosphate, KEGG map00561, http://www.genome.jp/kegg/) Fig. 1 Clustering of gastrointestinal regions' transcriptomes based on the 199 probe sets responsible for sample separability. Principal components analysis (PCA) (a) and hierarchical clustering (Ward's method) (b) analysis were conducted on the 18 samples, each individually represented on the graphs. The scale of b is the sum of the squares of the euclidean distance (the unit) for the cluster and it is based on a differential matrix. Consistency between A (PCA) and B supported the tree which was generated by hierarchical clustering. The scorings (samples) and loadings (probe sets) from PCA analysis were then mapped on the same plot, called a biplot (b). As a consequence of the matrix factorization X (log transformed and centered on 0), the modulation of any probe set can be geometrically inferred from its position on the biplot. Accordingly, when a probe set lies far from the origin and close to one chip, it is upregulated in this chip (gastrointestinal segment sample) compared to all the others and vice versa. The highest the distance of a probe set from the origin, the highest its modulation. The magnitude of modulation for each probe set is given as a numerical value (Norm value, Fig. 2) . A antrum, D duodenum, J jejunum, I ileum, C colon and that has not yet been characterized in human and has been found to be selective of proximal small intestine. A putatively novel transcription factor containing JmjC domains (FLJ13798, E = 7.8e -05 ) was identified as selective of proximal small intestinal regions but has not been further investigated since it was called absent by the Affymetrix algorithm. The colon-specific probe set 220724_at was assigned to a nuclease/phosphatase which, despite the low level of confidence (E = 0.16), was confirmed by fold recognition analysis (not shown). Finally, two probe sets (214046_at and 220645_at) remained unassigned, although the gene represented by 220645_at is called 99% similar to a brush border protein gene belonging to the same UniGene cluster. Based on UniGene's EST Profile Viewer, these 19 genes indeed were confirmed to be expressed in the GI segment to which they were found to be associated, except for CLIC3, FLJ13798, CML2, and SEMA6A for which complete information was not available. Subsequent particular analysis of gene expression modulation showed that the antrum was characterized by the modulation of genes encoding for several gastric proteins such as trefoil factors, progastricsin, and mucin 5AC (Fig. 2a) , as well as a gene encoding for the cytosolic sulfotransferase SULT1C1, a finding supported by previous research reporting sulfotransferase activity in the antral and body mucosa of human and rat stomachs. This enzyme catalyzes the transfer of a sulfate ester group from 3 0 -phosphoadenosine 5 0 -phosphosulfate to the carbohydrate chain of gastric mucus glycoproteins (Carter et al. 1988; Liau et al. 1983) . Another important finding was the identification of the b-microseminoprotein isoform-a precursor. This is a small disulfide-rich protein with unknown function that is present in the secretions of most mucosal surfaces in the body, including the stomach where it is secreted in the antrum by endocrine cells (Weiber et al. 1997) . The protein has been investigated as a biomarker of gastric carcinoids (Weiber et al. 1999) . (Fig. 1) were found to correspond to 166 genes selective of a antrum (36 genes); b duodenum (14 genes), duodenum and jejunum (57 genes), and jejunum (14 genes); c ileum (16 genes) and colon (29 genes). Their expression pattern along the gastrointestinal tract is visualized in the heat map that was constructed using the lntransformed average hybridization intensities calculated from three to four replicates (individuals). The gene description corresponds to the ENSEMBL and Affymetrix designation (grade 1), ENSEMBL only (grade 2), and Affymetrix only (grade 3), or was tentatively assigned as explained in the text (grade 4). The normalization (Norm) value, calculated by PCA, represents the importance of each gene in distinguishing the related gut segment from the others; values close to or higher than 2 correspond to high tissue selectivity. Bold indicates genes not previously described to be expressed in the corresponding gut region based on automated literature search, as explained in Materials and methods. A antrum, D duodenum, J jejunum, I ileum, C colon, na not applicable The whole experimental approach was clearly validated by finding that the unique probe set on the HG-U133A Affymetrix chip that was annotated to be antrum-specific was retrieved as being specifically modulated in this same region (probe set ID: 220191-at). The duodenum and jejunum (Fig. 2b) were characterized by the modulation of a large spectrum of proteolytic enzymes, a number of lipoprotein precursors, and several solute carrier proteins (transporters). A number of detoxifying enzymes that belong to the cytochrome P450 family were also modulated in these regions. In what concerned duodenum tissue only, modulation of the NPC1 gene was found remarkable. A deficiency in the function of this gene is related to the Niemann-Pick disease type C that is due to defective cholesterol intracellular transport (Liscum and Klansek 1998) . The jejunum was characterized by peptido-and glycohydrolytic activities due to the specific modulation of the related enzymes such as dipeptidylpeptidase, aminopeptidase, glucoamylase, and isomaltase. Several interesting genes appeared to be modulated in both duodenum and jejunum, such as vanin-1, which is involved in the biosynthesis of vitamin B (Martin et al. 2004) , and sterolin-1, which prevents dietary noncholesterol sterols from being absorbed (Klett and Patel 2003) . Among genes selective of ileum (Fig. 2c) , we found MUC2, which codes for a mucin associated with high colonic expression (Tytgat et al. 1994) . Analysis of the corresponding probe set position on the biplot (Fig. 1c) revealed that it is almost equidistant from ileum and colon, highlighting similar expression in the two regions. Accordingly, mucin 2, besides being dominant in colon mucins, could also be one of the main ileal mucins. An important novelty came from scrutiny of other genes selective of ileum, as we found evidence for the important modulation of semaphorin 6A1, a protein involved in neuronal development and regeneration during apoptosis that is discussed further below. The colon (Fig. 2c) was characterized by an elevated modulation of genes encoding for carbonic anhydrase precursors as well as for carcinoembryonic antigen-related cell adhesion molecules. Few other genes appeared to be modulated, e.g., aquaporin and the osteoblast specific factor 2.
Our analysis was validated once more by the finding of the known differential expression of the claudin family of tight junction proteins involved in paracellular transport (Rahner et al. 2001) . For instance, the expression of claudin 4 was found to be highly restricted to the colon, whereas claudin 18 was mainly expressed in the antrum. Knowledge of these expression patterns is significant as it has been proposed that they underlie differences in the paracellular permeability properties (Niimi et al. 2001 ). Among novel genes and genes not previously known to be expressed in the GI tract, we found several transmembrane proteins that seem to be important to gut regions in a specific manner. These include SEMA6A, FLJ22800, TSPAN1, and MS4A12. This has possible implications in the recognition of non-self molecules such as nutrients, pathogenic and commensal bacteria, or any other antigen, and subsequently generated signaling events in the enterocyte. For example, it has been suggested that SEMA6A plays a role in retrograde signaling to cytoskeletal elements by regulating proteins like Ena/VASP (Klostermann et al. 2000) . Interestingly, these proteins mediate intracellular movement of L. monocytogenes by linking the bacterium to the actin tail (Laurent et al. 1999) ; therefore, semaphorin 6A may play a role in pathogen infection in the small intestine. We suggest that FLJ22800 is a new L6 type of protein, based on protein sequence analysis. L6 proteins are surface proteins characterized by four transmembrane domains and constitute a family of four members: L6, IL-TMP, TM4SF5, and L6D (Wright et al. 2000) . The biological function of these proteins is not completely understood, although they have been implicated in signal transduction events. Moreover, it has been suggested that they mediate tumor cell metastasis and cell adhesion (Kao et al. 2003) . All except L6D are represented on the Affymetrix U133A chip used in this study so we could therefore examine their expression pattern. They all appear to have very low expression in colon and enriched expression in the proximal small intestine. It is notable that IL-TMP has been identified in this study as a descriptor of duodenum. TM4SF5 is the only one expressed in the antrum, while L6 seems to be the only one not expressed in the GI tract, even though this should be confirmed by independent assays. L6 proteins were previously considered to be tetraspanins (Maecker et al. 1997; Marken et al. 1992 ) because of their similar topological features. Tetraspanins are transmembrane proteins that support and stabilize the formation of signaling complexes (Maecker et al. 1997) . The expression of several tetraspanins as well has been shown to be highly regulated along the GI tract (Okochi et al. 1999) . We found TSPAN1 (transmembrane protein tetraspanin-1) to be a gene selective of colon. Of all members of the tetraspanin family, TSPAN-1 is most similar to CD81 (Todd et al. 1998) , which is expressed in olfactory neurons. The specific role of TSPAN-1 in colon is still unknown. Finally, MS4A12 is a member of the membrane-spanning 4A gene family, whose expression pattern and biological role are unknown even though it has been suggested to be involved in signal transduction, as are the other family members (Liang and Tedder 2001) . The high expression level and modulation value in colon, as well as the fact that no ESTs have been found in any tissue but colon, suggest that this gene is colon-specific.
Taken as a whole, these data represent the first mapping of the healthy adult human gastrointestinal transcriptome.
Identification and expression pattern analysis of ileum and colon selective genes in IBD To show the effective use of our approach when studying gene expression deviation in gut pathologies, we reanalyzed the GEO data set GSE1152 that contains gene expression profiles corresponding to the ileum and colon of Crohn's, ulcerative colitis (UC), and control patients (Langmann et al. 2004) . In that study, the same microarray platform used here was employed. First we explored regional clustering in the IBD condition by applying the approach described above. We carried out a global analysis of the data using the 22,283 probe sets and all the samples crossing the regions (ileum and colon) and conditions (healthy, Crohn's, and UC). We reduced the original data set to only the significant probe sets (329) using their magnitudes. When performing PCA on this subset we were able to see a clear stratification according to the disease rather than to the region type (Fig. 3) , which confirmed previous observations (Langmann et al. 2004 ). This withstanding, the gene expression profile in ileum from UC patients tends to approach that of the control samples, which shows that the transcriptome of this organ is only slightly affected by this disease compared to transverse colon. Finally, 37 of the 45 genes found to be selective of the healthy ileum and colon in our data set (Fig. 2) were modulated in the IBD state, with an absolute fold higher than 1.5 (Supplementary Table 2 ). Next, we carried out a more detailed analysis by region and by disease. Because we lacked replicates from the GSE1152 data set since samples had been pooled per condition, we were not able to select probe sets statistically; therefore, we took into account the expression level and the density of the probe sets and selected the highly modulated ones, both by intestinal region and by disease, using a binning and skimming technique. We constructed a plot of the log 2 fold (disease/healthy) versus the mean log 2 expression, thus identifying highly variable probe sets independent from the level of expression. These probe sets were then crossed with the 199 descriptor probe sets identified by our previous analysis (Fig. 1, Supplementary Table 1) . The genes thus selected are represented in Fig. 4 .
The ''by region'' analysis (Fig. 4, spots) shows that both Crohn's and ulcerative colitis modulate gastrokine 1 (GKN1) and mucin5AC (MUC5AC) in ileum and calciumactivated chloride channel 4 (CLCA4) and mucin5B (MUC5B) in colon. The ''by disease'' analysis (Fig. 4 , dotted grid) shows that none of the region-specific biomarker genes is modulated by Crohn's disease in both ileum and colon, while peptide YY (PYY) is jointly modulated by colitis in both regions. Specifically modulated genes include mucin and cadherin like (MUCDHL) and G protein-coupled receptor family C group 5 member B (GPRC5B) downregulated in Crohn's ileum, liver fatty acid binding protein L-FABP downregulated in colitis ileum, sulfate transporter (SLC26A2) and carcinoembryonic antigen-related cell adhesion molecule 7 (CEACAM7) upregulated in Crohn's colon, tetraspanin-1 (TSPAN-1) downregulated in Crohn's colon, and finally glycogene phosphorylase brain form (PYGB) and gastrotropin or ileal fatty acid binding protein (ILBP) downregulated in colitis colon. Interaction network analysis suggested that these genes are more likely to be involved in independent biological pathways (data not shown). CEACAM7 is a member of the carcinoembryonic antigen (CEA) family and is found only at the apical surface of highly differentiated epithelial cells in the colorectal mucosa (Scholzel et al. 2000) . Interestingly, its expression correlates with apoptosis in the normal colon. Increased gene expression in inflamed compared to healthy epithelium may therefore relate to an alteration of the apoptotic pathway accompanied by increased apoptosis, which has recently been suggested to be implicated in the IBD pathology (Verstege et al. 2006) . Moreover, The Ca 2? -activated chloride channel 4 (CLCA4), which we had found to be the main discriminator of the healthy colon (highest Norm value, Fig. 2 ), is supposed to upregulate the transmembrane potential and mediate secretion of electrolytes and water (Eggermont 2004) . Its upregulation in Crohn's and UC patients may be related to the onset of diarrhea resulting from increased Cl -secretion. Finally, PYGB, a key enzyme in glycogen degradation involved in calcium and insulin signaling, has been identified in colon. PYGP is not detected in any other region examined in this study and is a strong colon classifier (Norm value = 1.83, Fig. 2 ). This gene has been proposed to be a marker of carcinogenesis (Tashima et al. 2000) . Since IBD patients are at higher risk of developing colorectal cancer, the identification of this gene as a descriptor of UC in colon may be diagnostically relevant.
In summary, PCA could differentiate between the transcriptomes from Crohn's patients and those from colitis and healthy patients based on the selected 329 genes. This withstanding, when looking for descriptors of each regiondisease association, we found both genes specific to each of the conditions considered and genes commonly modulated in both diseases and regions (except for ileum and colon of Crohn's patients).
Conclusions
This study provides the first map of gene expression in various compartments of the healthy human adult gastrointestinal tract and a biomathematical information compression approach for the selection of longitudinally differentially expressed genes. The analysis uncovered clear differences in the levels of gene expression among the five Fig. 4 Genes associated with ulcerative colitis (UC) and/or Crohn's disease in the ileum and/or colon. Genes were identified by a ''by region'' (ileum and colon) and a 'by disease'' (UC and Crohn's) analysis, as explained in the text. Solid and dashed boxes indicate genes associated with UC and Crohn's, respectively. Genes in the spots area were modulated in one of the two regions in both diseases, and genes in the dotted grid area were modulated in both regions in one of the diseases. Arrows indicate up-and downregulation Fig. 3 Clustering of healthy and inflamed ileum and colon transcriptomes. PCA was conducted on the Affymetrix expression data obtained from the healthy and affected ileum and transverse colon of Crohn's and ulcerative colitis patients (data from the GEO data set GSE1552) using the 329 most significant genes (i.e., the genes preselected by PCA to be responsible for samples separability). I ileum, C colon, Con control, Cro Crohn's, Col colitis regions under scrutiny in the healthy condition. In particular, it allowed differentiation between the transcriptomes of duodenum and jejunum, which had not been possible in a previous study of gene expression in the murine healthy GI tract (Bates et al. 2002) . Furthermore, the approach was applied to an existent data set of gene expression in the intestine of patients affected by Crohn's disease and ulcerative colitis, two manifestations of inflammatory bowel disease. We were therefore able to identify interesting new leads in both the healthy and the disease state. These data furnish a basis for understanding the complex role played by the intestinal epithelium in the maintenance of intestinal homeostasis.
